Alnylam Pharmaceuticals (ALNY) Common Equity (2009 - 2026)
Alnylam Pharmaceuticals' Common Equity came in at $1.35 billion for Q2 2026, up 143.8% from $555.35 million a year earlier and up 25.9% from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Common Equity (2009 - 2026) Analysis & Trends
At the end of FY2025, Alnylam Pharmaceuticals' Common Equity was $789.18 million.
- Common Equity carries a five-year compound annual growth rate of -4.9% (FY2020 to FY2025).
- Going back by year, Common Equity was $67.09 million in FY2024, -$220.64 million in FY2023, -$158.22 million in FY2022 and $588.2 million in FY2021 (-42.1%).
- The Q2 2026 figure represents the highest quarterly Common Equity since Q2 2020.
- Business Quant data shows ALNY's Common Equity at $1.08 billion (Q1 2026), $789.18 million (Q4 2025) and $233.89 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Alnylam Pharmaceuticals | 34.23 Bn | 22.28 Bn | 992.69 Mn | 1.35 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.35 Bn |
| Mar 31, 2026 | 1.08 Bn |
| Dec 31, 2025 | 789.18 Mn |
| Sep 30, 2025 | 233.89 Mn |
| Jun 30, 2025 | 555.35 Mn |
| Mar 31, 2025 | 426.14 Mn |
| Dec 31, 2024 | 67.09 Mn |
| Sep 30, 2024 | 32.35 Mn |
| Jun 30, 2024 | -3.07 Mn |
| Mar 31, 2024 | -219.27 Mn |
| Dec 31, 2023 | -220.64 Mn |
| Sep 30, 2023 | -165.87 Mn |
| Jun 30, 2023 | -408.13 Mn |
| Mar 31, 2023 | -259.24 Mn |
| Dec 31, 2022 | -158.22 Mn |
| Sep 30, 2022 | -67.64 Mn |
| Jun 30, 2022 | 176.04 Mn |
| Mar 31, 2022 | 401.17 Mn |
| Dec 31, 2021 | 588.20 Mn |
| Sep 30, 2021 | 755.89 Mn |
API Access
Alnylam Pharmaceuticals Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();